Current and historical daily PE Ratio for Getinge AB (
OSTO:GETI B
) from 1998 to Jun 11 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Getinge AB stock (OSTO:GETI B) PE ratio as of Jun 11 2024 is 21.81.
More Details
Getinge AB (OSTO:GETI B) PE Ratio (TTM) Chart
Getinge AB (OSTO:GETI B) PE Ratio (TTM) Historical Data
View and export this data going back to 1998. Start your Free Trial
Total 1284
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Getinge AB PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-11 | 21.8 | 2024-04-04 | 25.3 |
| 2024-06-10 | 21.8 | 2024-04-03 | 24.9 |
| 2024-06-07 | 22.5 | 2024-04-02 | 24.8 |
| 2024-06-05 | 22.2 | 2024-03-28 | 25.6 |
| 2024-06-04 | 22.2 | 2024-03-27 | 24.5 |
| 2024-06-03 | 22.4 | 2024-03-26 | 23.8 |
| 2024-05-31 | 22.3 | 2024-03-25 | 24.0 |
| 2024-05-30 | 22.5 | 2024-03-22 | 23.5 |
| 2024-05-29 | 22.3 | 2024-03-21 | 23.3 |
| 2024-05-28 | 22.8 | 2024-03-20 | 23.3 |
| 2024-05-27 | 22.9 | 2024-03-19 | 23.7 |
| 2024-05-24 | 22.7 | 2024-03-18 | 23.6 |
| 2024-05-23 | 22.5 | 2024-03-15 | 24.2 |
| 2024-05-22 | 22.1 | 2024-03-14 | 24.1 |
| 2024-05-21 | 22.2 | 2024-03-13 | 24.1 |
| 2024-05-20 | 22.0 | 2024-03-12 | 23.5 |
| 2024-05-17 | 22.1 | 2024-03-11 | 23.3 |
| 2024-05-16 | 22.6 | 2024-03-08 | 23.4 |
| 2024-05-15 | 22.8 | 2024-03-07 | 23.2 |
| 2024-05-14 | 25.9 | 2024-03-06 | 22.9 |
| 2024-05-13 | 25.4 | 2024-03-05 | 23.0 |
| 2024-05-10 | 25.2 | 2024-03-04 | 23.0 |
| 2024-05-08 | 27.7 | 2024-03-01 | 23.4 |
| 2024-05-07 | 28.0 | 2024-02-29 | 23.2 |
| 2024-05-06 | 27.7 | 2024-02-28 | 23.1 |
| 2024-05-03 | 27.6 | 2024-02-27 | 23.5 |
| 2024-05-02 | 27.6 | 2024-02-26 | 23.6 |
| 2024-04-30 | 28.0 | 2024-02-23 | 23.6 |
| 2024-04-29 | 28.5 | 2024-02-22 | 23.6 |
| 2024-04-26 | 28.0 | 2024-02-21 | 23.5 |
| 2024-04-25 | 27.3 | 2024-02-20 | 23.6 |
| 2024-04-24 | 27.6 | 2024-02-19 | 23.2 |
| 2024-04-23 | 27.6 | 2024-02-16 | 23.2 |
| 2024-04-22 | 27.6 | 2024-02-15 | 22.9 |
| 2024-04-19 | 25.3 | 2024-02-14 | 22.4 |
| 2024-04-18 | 25.0 | 2024-02-13 | 22.1 |
| 2024-04-17 | 25.4 | 2024-02-12 | 22.4 |
| 2024-04-16 | 25.7 | 2024-02-09 | 22.0 |
| 2024-04-15 | 25.5 | 2024-02-08 | 22.0 |
| 2024-04-12 | 25.0 | 2024-02-07 | 22.1 |
| 2024-04-11 | 25.4 | 2024-02-06 | 22.5 |
| 2024-04-10 | 25.3 | 2024-02-05 | 21.9 |
| 2024-04-09 | 25.8 | 2024-02-02 | 22.3 |
| 2024-04-08 | 25.9 | 2024-02-01 | 22.2 |
| 2024-04-05 | 25.1 | 2024-01-31 | 25.3 |
Getinge AB (OSTO:GETI B) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Getinge AB
NAICS : 339112
ISIN : SE0000202624
Share Class Description:
OSTO:GETI B: Class BCompare
Compare
Traded in other countries / regions
GETI B.Sweden0GZV.UKGNGBY.USAGTN.GermanyGETIB.Mexico IPO Date
1998-02-01Description
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers